Trial Profile

Pilot Study of Effects of Duavee on Imaging and Blood Biomarkers In Women With Menopausal Symptoms at Increased Risk for Breast Cancer

Status: Discontinued

Phase of Trial: Phase 0

Latest Information Update: 05 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Conjugated estrogens/bazedoxifene (Primary)
Indications Atrophic vaginitis; Breast cancer; Postmenopausal osteoporosis; Vasomotor symptoms
Focus Biomarker; Therapeutic Use

Most Recent Events

10 Apr 2024 Results presented at the 115th Annual Meeting of the American Association for Cancer Research
22 Oct 2021 Status changed from active, no longer recruiting to discontinued.
18 Mar 2021 Planned number of patients changed from 20 to 30.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com